Gibson Capital »

Regeneron Pharmaceuticals shares owned by Gibson Capital

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Gibson Capital from 13F filings

Historical chart of Gibson Capital investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Gibson Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Gibson Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $187k 178 1051.24
2024-06-30 $284k 270 1051.03

More positions owned by Gibson Capital

Vanguard Total Stock Market Etf Etf (VTI)
Vanguard Real Estate Etf Etf (VNQ)
Dimensional Us Sustainability Core 1 Etf Etf (DFSU)
Berkshire Hathaway Inc Del Cl A Stock (BRK.A)
Bridgeway Omni Small Cap Value Tax-managed Etf Etf (BSVO)
Vanguard Large-cap Etf Etf (VV)
Vanguard Dividend Appreciation Etf Etf (VIG)
Dimensional U.s. Targeted Value Etf Etf (DFAT)
Ishares Gold Trust Etf (IAU)
Berkshire Hathaway Inc Del Cl B Stock (BRK.B)
Ishares Msci Kld 400 Social Etf Etf (DSI)
Vanguard Mid-cap Etf Etf (VO)
Apple Stock (AAPL)
Avantis International Small Cap Value Etf Etf (AVDV)
Meridianlink Stock (MLNK)

View all positions for Gibson Capital

Top funds holding Regeneron Pharmaceuticals

FMR
Vanguard Group
BlackRock
Jpmorgan Chase & Co
State Street Corporation
Capital World Investors
Capital Research and Management Company - Division 3
Dodge & Cox
Geode Capital Management
Franklin Resources
T. Rowe Price Associates
Loomis, Sayles and
Invesco
Bank of America Corporation
Amundi

View all funds holding Regeneron Pharmaceuticals